[Effect of basic fibroblast growth factor on development of Parkinson syndrome in mice].
Kryzhanovskiĭ
G N
GN
Kucherianu
V G
VG
Nikushkin
E V
EV
Krupina
N A
NA
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D000281:Administration, Intranasal; D000818:Animals; D016222:Fibroblast Growth Factor 2 / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000517:prevention & control*
D016222:Fibroblast Growth Factor 2; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine